Drug Price Trends for NDC 00904-7458

Average Pharmacy Cost for 00904-7458

Drug Name	NDC	Price/Unit ($)	Unit	Date
PANTOPRAZOLE SOD DR 20 MG TAB	00904-7458-61	0.04777	EACH	2025-05-21
PANTOPRAZOLE SOD DR 20 MG TAB	00904-7458-61	0.04740	EACH	2025-04-23
PANTOPRAZOLE SOD DR 20 MG TAB	00904-7458-61	0.04727	EACH	2025-03-19
PANTOPRAZOLE SOD DR 20 MG TAB	00904-7458-61	0.04529	EACH	2025-02-19
PANTOPRAZOLE SOD DR 20 MG TAB	00904-7458-61	0.04207	EACH	2025-01-22

Best Wholesale Price for NDC 00904-7458

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type

Market Analysis and Price Projections for Drug NDC: 00904-7458

The pharmaceutical industry is constantly evolving, with new drugs entering the market and existing ones facing changes in demand, pricing, and regulatory landscapes. One such drug that warrants attention is identified by the National Drug Code (NDC) 00904-7458. This article delves into a comprehensive market analysis and price projections for this specific drug, offering insights that could be valuable for industry professionals, investors, and healthcare providers.

Understanding NDC 00904-7458

Before we dive into the market analysis, it's crucial to understand what NDC 00904-7458 represents. The National Drug Code is a unique, three-segment number assigned to human drugs in the United States. It serves as a universal product identifier for drugs[8]. The code 00904-7458 corresponds to Pantoprazole Sodium, manufactured by Major Pharmaceuticals[2].

Pantoprazole Sodium is a proton pump inhibitor (PPI) used to treat certain stomach and esophagus problems such as acid reflux. It works by decreasing the amount of acid produced by the stomach.

Current Market Position

As of 2025, Pantoprazole Sodium holds a significant position in the gastrointestinal drug market. Its effectiveness in treating acid-related disorders has made it a popular choice among healthcare providers and patients alike.

Generic drug prices are consistently lower than brand-name prices across all market sizes and time periods, with the largest cost savings in larger markets and for drugs that have been on the market longer[5].

This trend bodes well for Pantoprazole Sodium, as it's a generic version of the original brand-name drug. The lower price point makes it more accessible to a broader patient base, potentially increasing its market share.

Factors Influencing Market Dynamics

Several factors are shaping the market dynamics for Pantoprazole Sodium:

1. Aging Population

The global aging population is a significant driver for gastrointestinal drugs. As people age, they become more susceptible to acid reflux and related conditions, increasing the demand for drugs like Pantoprazole Sodium.

2. Lifestyle Changes

Modern lifestyle changes, including poor dietary habits and increased stress levels, have led to a rise in gastrointestinal issues. This trend is likely to continue, potentially expanding the market for Pantoprazole Sodium.

3. Regulatory Environment

The regulatory landscape plays a crucial role in drug pricing and availability. Any changes in FDA regulations or healthcare policies could significantly impact the market for Pantoprazole Sodium.

4. Competition

The presence of other PPIs and alternative treatments in the market affects the demand and pricing of Pantoprazole Sodium. Monitoring competitor strategies and product developments is crucial for accurate market projections.

Price Projections

Projecting drug prices involves considering multiple factors, including production costs, market demand, and competitive landscape. For Pantoprazole Sodium (NDC: 00904-7458), the following trends are likely to influence its pricing:

1. Generic Drug Pricing Trends

As a generic drug, Pantoprazole Sodium typically offers significant cost savings compared to brand-name alternatives. This price advantage is expected to continue, making it an attractive option for both patients and healthcare providers.

2. Market Competition

The presence of other generic versions of Pantoprazole and alternative PPIs may exert downward pressure on prices. However, established manufacturers like Major Pharmaceuticals may maintain a pricing edge due to their reputation and supply chain efficiencies.

3. Production Costs

Any fluctuations in raw material costs or changes in manufacturing processes could impact the pricing of Pantoprazole Sodium. However, as an established generic drug, significant price volatility is less likely.

4. Healthcare Policies

Changes in healthcare policies, such as adjustments to Medicare or Medicaid reimbursement rates, could influence the pricing strategy for Pantoprazole Sodium.

Market Segmentation

Understanding the market segmentation for Pantoprazole Sodium is crucial for accurate analysis and projections:

1. Geographical Segmentation

The demand and pricing for Pantoprazole Sodium may vary across different regions due to factors such as local healthcare policies, population demographics, and economic conditions.

2. End-User Segmentation

The drug serves various end-users, including hospitals, retail pharmacies, and online pharmacies. Each segment may have different pricing structures and demand patterns.

3. Dosage Segmentation

Pantoprazole Sodium is available in different dosages, each potentially having its own market dynamics and pricing trends.

Future Market Outlook

The future market for Pantoprazole Sodium (NDC: 00904-7458) appears promising, driven by several factors:

1. Increasing Prevalence of Acid-Related Disorders

The rising incidence of conditions like gastroesophageal reflux disease (GERD) is likely to boost demand for Pantoprazole Sodium.

2. Expanding Generic Drug Market

The global trend towards generic drugs to reduce healthcare costs favors the market position of Pantoprazole Sodium.

3. Technological Advancements

Improvements in drug delivery systems or formulations could enhance the efficacy of Pantoprazole Sodium, potentially increasing its market appeal.

4. Emerging Markets

Expansion into emerging markets could open new growth avenues for Pantoprazole Sodium, subject to regulatory approvals and local market conditions.

Challenges and Opportunities

While the market outlook for Pantoprazole Sodium is generally positive, there are both challenges and opportunities to consider:

Challenges:

1. Intense Competition: The PPI market is highly competitive, with numerous generic and brand-name options available.

2. Regulatory Hurdles: Stringent regulatory requirements can impact market entry and pricing strategies.

3. Side Effect Concerns: Long-term use of PPIs has been associated with certain health risks, which could influence prescribing patterns.

Opportunities:

1. Digital Health Integration: Incorporating Pantoprazole Sodium into digital health platforms could enhance patient adherence and market penetration.

2. Combination Therapies: Developing combination therapies with Pantoprazole Sodium could open new market segments.

3. Patient Education: Increasing awareness about acid-related disorders and treatment options could drive demand for Pantoprazole Sodium.

Impact of NDC Changes

The pharmaceutical industry is preparing for a significant change in the National Drug Code (NDC) system. The FDA is running out of NDC numbers, necessitating a restructuring of the system[1]. This change could have far-reaching implications for all drugs, including Pantoprazole Sodium (NDC: 00904-7458).

Nearly every system will be impacted. It is like Y2K for pharmacy![1]

This transition could affect various aspects of drug management, including inventory systems, prescription processing, and reimbursement procedures. Manufacturers, distributors, and healthcare providers will need to update their systems to accommodate the new NDC format.

Key Takeaways

• Pantoprazole Sodium (NDC: 00904-7458) is a generic proton pump inhibitor with a strong market position in the gastrointestinal drug segment.
• The aging population and lifestyle changes are driving increased demand for acid reflux treatments.
• As a generic drug, Pantoprazole Sodium offers cost advantages, but faces competition from other generic and brand-name alternatives.
• Future market growth is supported by the increasing prevalence of acid-related disorders and the global trend towards generic drugs.
• The impending changes to the NDC system present both challenges and opportunities for all stakeholders in the pharmaceutical supply chain.
• Continuous monitoring of regulatory changes, market trends, and competitive landscape is crucial for accurate price projections and market analysis.

FAQs

1. Q: How might the upcoming NDC system changes affect the pricing of Pantoprazole Sodium? A: The NDC system changes could potentially impact pricing indirectly through increased costs associated with system updates and potential supply chain disruptions. However, the long-term effect on pricing is expected to be minimal.

2. Q: What are the main factors that could lead to price fluctuations for Pantoprazole Sodium in the near future? A: Key factors include changes in production costs, shifts in market demand, alterations in healthcare policies, and the introduction of new competing drugs or treatment methods.

3. Q: How does the market for Pantoprazole Sodium differ between developed and emerging markets? A: In developed markets, Pantoprazole Sodium often competes with numerous other generic and brand-name PPIs. In emerging markets, it may face less competition but could encounter challenges related to market entry, regulatory approval, and establishing distribution networks.

4. Q: What role does patient adherence play in the market dynamics of Pantoprazole Sodium? A: Patient adherence is crucial for the sustained market success of Pantoprazole Sodium. Higher adherence rates can lead to better treatment outcomes, potentially increasing prescription rates and overall market demand.

5. Q: How might advancements in alternative treatments for acid reflux impact the future market for Pantoprazole Sodium? A: Advancements in alternative treatments, such as minimally invasive surgical procedures or novel drug therapies, could potentially reduce the market share of PPIs like Pantoprazole Sodium. However, the established efficacy and safety profile of PPIs are likely to maintain their significant market presence in the foreseeable future.

Sources cited: [1] https://www.wolterskluwer.com/en/expert-insights/are-you-prepared-for-a-major-industry-change-to-the-national-drug-code-ndc-number [2] https://www.findacode.com/ndc/labelers/Major_Pharmaceuticals [5] https://aspe.hhs.gov/sites/default/files/documents/510e964dc7b7f00763a7f8a1dbc5ae7b/aspe-ib-generic-drugs-competition.pdf [8] https://www.nber.org/research/data/national-drug-code

Last updated: 2025-01-29